Researcher profile

Alexei Larionov

Alexei Larionov contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Review of opportunities at the HESR-Collider with PANDA at FAIR

Exciting new scientific opportunities are presented for the PANDA detector at the High Energy Storage Ring in the redefined $\overline{\text{p}} \text{p}(A)$ collider mode, HESR-C, at the Facility for Antiproton and Ion Research (FAIR) in Europe. The high luminosity, $L \sim 10^{31}$ cm$^{-2}$ s$^{-1}$, and a wide range of intermediate and high energies, $\sqrt{s_{\text{NN}}}$ up to 30 GeV for $\overline{\text{p}} \text{p}(A)$ collisions will allow to explore a wide range of exciting topics in QCD, including the study of the production of excited open charm and bottom states, nuclear bound states containing heavy (anti)quarks, the interplay of hard and soft physics in the dilepton production, probing short-range correlations in nuclei, and the exploration of the early, complete $\overline{\text{p}}$-p-annihilation phase, where an intially pure Yang-Mills gluon plasma is formed.

preprint2007arXiv

PET monitoring of cancer therapy with He-3 and C-12 beams: a study with the GEANT4 toolkit

We study the spatial distributions of $β^+$-activity produced by therapeutic beams of $^3$He and $^{12}$C ions in various tissue-like materials. The calculations were performed within a Monte Carlo model for Heavy-Ion Therapy (MCHIT) based on the GEANT4 toolkit. The contributions from $^{10,11}$C, $^{13}$N, $^{14,15}$O, $^{17,18}$F and $^{30}$P positron-emitting nuclei were calculated and compared with experimental data obtained during and after irradiation. Positron emitting nuclei are created by $^{12}$C beam in fragmentation reactions of projectile and target nuclei. This leads to a $β^+$-activity profile characterised by a noticeable peak located close to the Bragg peak in the corresponding depth-dose distribution. On the contrary, as the most of positron-emitting nuclei are produced by $^3$He beam in target fragmentation reactions, the calculated total $β^+$-activity during or soon after the irradiation period is evenly distributed within the projectile range. However, we predict also the presence of $^{13}$N, $^{14}$O, $^{17,18}$F created in charge-transfer reactions by low-energy $^3$He ions close to the end of their range in several tissue-like media. The time evolution of $β^+$-activity profiles was investigated for both kinds of beams. Due to the production of $^{18}$F nuclide the $β^+$-activity profile measured 2 or 3 hours after irradiation with $^{3}$He ions will have a distinct peak correlated with the maximum of depth-dose distribution. We found certain advantages of low-energy $^{3}$He beams over low-energy proton beams for reliable PET monitoring during particle therapy of shallow located tumours. In this case the distal edge of $β^+$-activity distribution from $^{17}$F nuclei clearly marks the range of $^{3}$He in tissues.